Elevated care & ROI through AI intelligence
Boost your bottom line. We support your improved health outcomes and quality ratings. Our integrated partner model helps tackle your most expensive population challenges and support your care teams, giving you a strategic edge with unmatched clinical excellence.
Proven cost reduction for high-cost members
Enhance your care management programs with clinically rigorous, regulatory-grade AI
Welldoc delivers unified cardiometabolic care powered by healthcare-ready AI that adapts to your needs. Our platform seamlessly integrates with and scales your existing care teams and workflows, providing the clinical rigor healthcare demands and the flexibility your members deserve.
The result? Proven savings, improved quality measures, engaged members, and better outcomes across the conditions that drive your costs.
More than a healthcare app
Case study
Drive cost savings with diabetes self-management
In partnership with a large national health plan, this study assessed the impact of a technology-enabled diabetes self-management solution on health outcomes and costs for members with type 2 diabetes.
Meaningful, real-world results
- Reduced emergency room visits:
55% reduction in all-cause ER visits and 30% reduction in diabetes-related ER visits4 - Measurable clinical improvement:
Participants with a starting A1C greater than 8% saw a 1.83 average percentage point reduction in A1C5 - Proven cost effectiveness:
55% decrease in costs from baseline to follow-up, confirming a scalable approach to economic outcome4
Related resources
View All Resources
Get a customized ROI analysis for your member population
Check out the proven financial benefits and estimated savings tailored to your health plan's specific population and goals.
.png)
.avif)
1. IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
2. Welldoc Data on File. Based on data from: Shomali, MD, CM M, Salgado S, Ebert M, Iyer, PhD, MBA A. A Novel Approach to Estimating Cost Savings and Return on Investment (ROI) for Weight/BMI Changes with Digital Health. Poster presented at: ADA 2025 Scientific Sessions, June 2025.
3. Quinn, C.C. Shardell, M.D. Terrin, M.L. Barr, E.A. Ballew, S.H. Gruber-Baldini, A.L. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011 Sep;34(9):1934-42. Erratum in: Diabetes Care. 2013 Nov;36(11):3850.
4. Snow K, Iyer Phd A, Shearer D, Peeples M. Interactive Digital Health: Engaging Healthy Behaviors & Clinical Outcomes.; 2020. Poster. Welldoc partnered with Lifescan in a prospective study utilizing Lifescan’s OneTouch Reveal Plus
5. Welldoc data on file.
*Welldoc® Rx is an FDA-cleared medical device, intended for use by healthcare providers and their adult patients with type 1 or type 2 diabetes. For full labeling information, visit welldoc.com/indications-for-use/. The other Welldoc App products are non-FDA-cleared and intended to promote general wellness and education/self-management of various chronic disease states.